Paediatric Haematology and Oncology Clinical Trials

Currently Open Paediatric Haematology/Oncology Trials
Protocol Number
ACCT003
Protocol Name
Phase 1/11 study of valproate and interferon for
relapsed, recurrent or progressive neuroblastoma
Age Range
≤ 21 years at diagnosis
Criteria
Relapsed, recurrent or progressive neuroblastoma
Centre(s)
Starship Children's Hospital
ACCT007
Phase I Study of Vinorelbine, Cyclophosphamide and
Rapamycin for Recurrent Malignancies in Children
< 22 years
Solid tumour incl some CNS
Must meet organ function and performance criteria
Starship Children's Hospital/ Christchurch Hospital
ASSG-AYAPK
Pharmacokinetics and pharmacodynamics of
Doxorubicin
1 year - 40 years
Newly diagnosed osteosarcoma, Ewing family of
tumours or Hodgkin Lymphoma
Starship Children's Hospital
COG AALL0434
Intensified MTX, Nelarabine and Augmented BFM
Therapy for Children and Young Adults with Newly
Diagnosed T-cell ALL or T-cell NHL
> 1 year - < 31 years
Starship Children's Hospital/ Christchurch Hospital
COG AALL08B1
Classification of newly diagnosed ALL
< 31 years
COG AALL0932
Treatment of Patients with Newly Diagnosed Standard B-ALL: >365 days <10 years
Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B- B-LLy: >365 days < 31 years
lineage Lymphoblastic Lymphoma (B-LLy)
Newly diagnosed T-ALL or T-NHL (Stage II-IV)
No prior cytotoxic chemotherapy with the exception of
steroids and/or IT cytarabine
No Down’s Syndrome
Newly diagnosed acute leukaemia (suspect
lymphoblastic)
B-ALL: NCI Standard Risk; WCC <50000
B-Lly: Murphy Stage I-II
Tissue
submission
COG AALL1131
A Phase III Randomised Trial for Newly Diagnosed High > 365 days - < 31years
Risk B-precursor ALL testing Clofarabine in the Very
High Risk Stratum
COG AAML1031
A Phase III Randomised Trial for Patients with de novo
AML using Bortezomib and Sorafenib for Patients with
High Allelic Ratio FLT3/ITD
COG ABTR01B1
Collecting and Banking Paediatric Research Specimens ≤ 30 years
including Rare Paediatric Tumours
Specimen submission per protocol
Starship Children's Hospital
COG ACNS02B3
CNS Banking Study
No age restrictions
Specimen submission per protocol
Starship Children's Hospital
COG ACNS0331
Limited Target Volume Boost Irradiation and Reduced
Dose Cranio-spinal Rtx and Chemotherapy in Children
with Newly Diagnosed Standard Risk Medulloblastoma
Only ages 3-7 years
Histologically confirmed intracranial medulloblastoma minimal volume non-metastatic
Starship Children's Hospital/ Christchurch Hospital
COG ACNS0821
Medulloblastoma/CNS PNET Recurrent/Refractory
1 - 21 years
Relapsed, recurrent or refractory medulloblastoma/CNS Starship Children's Hospital/ Christchurch Hospital
PNET; histological confirmation at diagnosis or
recurrence; measurable disease.
COG ACNS0822
A Randomized Phase II/III Study of Vorinostat (IND#
≥ 3 - < 22 years
71976) and Local Irradiation OR Temozolomide and
Local Irradiation OR Bevacizumab and Local Irradiation
Followed by Maintenance Bevacizumab (IND # 7921)
and Temozolomide in Newly Diagnosed High Grade
Glioma
Must meet disease, timing and organ function criteria
Tissue submission required
Starship Children's Hospital
COG ACNS0831
Ependymoma Newly Diagnosed
1year - 21 years
Starship Children's Hospital
COG ACNS1022
A Phase II Randomized Trial of Lenalidomide (NSC #
703813, IND # 70116) in Pediatric Patients with
Recurrent, Refractory or Progressive Juvenile Pilocytic
Astrocytoma and Optic Pathway Gliomas
< 22 years
Histologically confirmed intracranial ependymoma nonmetastatic
Must have measurable disease
Must meet performance and organ function criteria
Strict mandatory contraception advice processes
< 30 years
Starship Children's Hospital/ Christchurch Hospital
Starship Children's Hospital/ Christchurch Hospital
Age: >365 days - < 10 years: WCC ≥ 50000
Age: ≥ Starship Children's Hospital/ Christchurch Hospital
10 years - < 31years: Any WCC
Any age: Any
WCC + Testicular involvement, CNS 3 or steroid pretreatment per protocol
De novo AML
Starship Children's Hospital/ Christchurch Hospital
This list is current at the time of posting and will be upated in May and November each year
Starship Children's Hospital/ Christchurch Hospital
Currently Open Paediatric Haematology/Oncology Trials
COG ACNS1123
Phase II Trial of Response-based Radiation Therapy for ≥ 3 years - ≤ 21 years
Patients with Localised CNS Germ Cell Tumours
Newly diagnosed, localised disease
Starship Children's Hospital/ Christchurch Hospital
COG AEPI10N5
Genetic Epidemiology of Ewing Sarcoma
Any
COG AEWS07B1
Ewing Tumour Biology and Banking Study
No age restrictions
Must have at least one biological parent willing to
participate
Requires submission of saliva and
Specimen submission per protocol
Starship Children's Hospital
COG AEWS1031
A Phase III Randomized Trial of Adding VincristineTopotecan-Cyclophosphamide to Standard
Chemotherapy in Initial Treatment of Non-metastatic
Ewing Sarcoma
Randomized Study of Chimeric Antibody 14.18
(Ch14.18) in High Risk Neuroblastoma Following
Myeloablative Therapy and Autologous Stem Cell
Rescue
≤ 50 years
Histologically confirmed Ewing’s of bone or soft tissue
No previous chemotherapy
No abnormal cardiac or renal function
< 31years
COG ANBL00B1
Neuroblastoma biology studies
No age restrictions
Diagnosis of HR neuroblastoma
Starship Children's Hospital/ Christchurch Hospital
Completed therapy including intensive induction followed
by ASCT and RT
No more than 9 months from 1st induction
chemotherapy after diagnosis to ASCT
Specimen submission per protocol
Starship Children's Hospital/ Christchurch Hospital
COG ANBL1221
Phase II Trial of Irinotecan/Temozolamide with
Temsirolimus or Ch 14.18 in Children with Relapsed,
Refractory or Progressive Neuroblastoma
No age restrictions
COG ANBL12P1
Pilot Study Using Myeloablative Busulfan/Melphalan
≤ 30 years
(BuMel) Consolidation Following Induction
Chemotherapy for Patients with Newly Diagnosed HighRisk Neuroblastoma
COG AOST06B1
Collecting and Banking Osteosarcoma Specimens
COG AREN03B2
COG ANBL0032
Starship Children's Hospital/ Christchurch Hospital
Starship Children's Hospital/ Christchurch Hospital
Starship Children's Hospital
Specimen submission per protocol
Starship Children's Hospital
Renal Tumour Classification, Banking and Biology Study < 30 years
Specimen submission per protocol
Starship Children's Hospital/ Christchurch Hospital
COG AREN0534
Bilateral Wilms tumours
Wilms tumour bilateral or bilaterally pre-disposed
Starship Children's Hospital/ Christchurch Hospital
COG ASCT1221
A Randomized Phase II Study Comparing Two Different ≥ 3 months - ≤ 18 years
Conditioning Regimens Prior to Allogeneic
Hematopoietic Cell Transplantation (HCT) for Children
with Juvenile Myelomonocytic Leukemia (JMML)
Must meet disease and function criteria
Starship Children's Hospital
COG D9902
Soft Tissue Sarcoma Biology and Banking
≤ 50 years
Specimen submission per protocol
Starship Children's Hospital/ Christchurch Hospital
CPT-SIOP-2009
Treatment Optimisation for Choroid Plexus Tumours
No age restrictions
Choroid Plexus Tumour newly diagnosed or recurrent
Starship Children's Hospital/ Christchurch Hospital
Interfant-06
Infant ALL
Up to 365 days
Newly diagnosed ALL / biphenotypic leukaemia
Starship Children's Hospital/ Christchurch Hospital
R3ACT
Therapeutic infusion of most closely HLA-matched third Any
party donor-derived virus-specific cytotoxic Tlymphocytes in patients with active viral reactivation postallogeneic stem cell transplantation
Randomised Phase III trial of the Efficacy of Sodium
> 1mth - ≤ 18yrs
Thiosulphate in reducing ototoxicity in patients receiving
Cisplatin chemotherapy for Standard Risk
Hepatoblastoma
Must meet disease, organ function and pre-treatment
criteria
Starship Children's Hospital
Histologically confirmed newly diagnosed
hepatoblastoma
Standard risk hepatoblastoma
Centre willing and able to organise audiometry
No abnormal renal function
Starship Children's Hospital/ Christchurch Hospital
SIOPEL 6
No age restrictions
Histological diagnosis of neuroblastoma or
ganglioneuroblastoma at diagnosis or recurrence;
measurable disease; first episode of recurrence or
progression
Must meet disease, organ function, performance and
timing criteria
Must enrol on NBL biology study
ANBL00B1
Starship Children's Hospital/ Christchurch Hospital
< 30 years
This list is current at the time of posting and will be upated in May and November each year